Valeant Puts Allergan On Defensive In $53B Buyout Fight
Reports swirled on Tuesday that Allergan Inc. is plotting out a series of defensive maneuvers as a hostile $53 billion takeover push mounted by Valeant Pharmaceuticals International Inc. gains momentum, playing...To view the full article, register now.
Already a subscriber? Click here to view full article